Research Article

Thirty-Day Outcomes following Pediatric Bone and Soft Tissue Sarcoma Surgery: A NSQIP Pediatrics Analysis

Table 2

Demographics and comorbidities with respect to tumor origin and location.

Soft tissue
N = 54
Median (IQR)
Bone
N = 138
Median (IQR)
valueAxial
N = 94
Median (IQR)
Appendicular
N = 98
Median (IQR)
value

Age, years7.5 (3–12.25)12 (7–14)0.00069 (3.75–12.25)12 (10–14)<0.0001
n (%)n (%)n (%)n (%)
Gender
 Male31 (57.4%)79 (57.2%)>0.999954 (57.4%)56 (57.1%)>0.9999
 Female23 (42.6%)59 (42.8%)40 (42.6%)42 (42.9%)
Racea
 White37 (68.5%)110 (79.7%)0.009666 (70.2%)81 (82.7%)0.158
 Black or African American8 (14.8%)5 (3.6%)9 (9.6%)4 (4.1%)
 Asian or Pacific Islander2 (3.7%)5 (3.6%)4 (4.3%)3 (3.1%)
 Unknown/not reported7 (13.0%)18 (13.0%)15 (16.0%)10 (10.2%)
Ethnicity
 Hispanic6 (11.1%)22 (15.9%)0.76219 (20.2%)9 (9.2%)0.065
 Non-Hispanic43 (79.6%)105 (76.1%)66 (70.2%)82 (83.7%)
 Unknown/not reported5 (9.3%)11 (8.0%)9 (9.6%)7 (7.1%)
Preop SIRS03 (2.2%)0.56003 (3.1%)0.246
Inotropic support01 (0.7%)>0.99991 (1.1%)00.490
Nutritional support1 (1.9%)7 (5.1%)0.4464 (4.3%)4 (4.1%)>0.9999
Recent steroid use3 (5.6%)20 (14.5%)0.13614 (14.9%)9 (9.2%)0.269
Cardiac risk factorsb
 Major cardiac risk factors03 (2.2%)0.4462 (2.1%)1 (1.0%)>0.9999
 Minor cardiac risk factors1 (1.9%)4 (2.9%)2 (2.1%)3 (3.1%)
History of pulmonary disease10 (18.5%)13 (9.4%)0.08910 (10.6%)13 (13.3%)0.659
Gastrointestinal disease07 (5.1%)0.1944 (4.3%)3 (3.1%)0.717
CNS disorder6 (11.1%)20 (14.5%)0.64322 (23.4%)4 (4.1%)<0.0001
Neuromuscular disorder3 (5.6%)7 (5.1%)>0.99998 (8.5%)2 (2.0%)0.054
Hematologic disorder6 (11.1%)20 (14.5%)0.64311 (11.7%)15 (15.3%)0.530
Previous childhood malignancy4 (7.4%)13 (9.4%)0.7832 (2.1%)15 (15.3%)0.0016

values calculated using Mann–Whitney U test for continuous variables and Fisher’s exact test or χ2 test for categorical variables. Significant values are in bold. aCalculated using Fisher’s exact test with African American versus other races. bCalculated using Fisher’s exact test with major or minor cardiac risk factors compared to no risk factors.